Chronic Lymphocytic Leukemia Coverage from Every Angle

Aging and Stereotypic B-Cell Receptors Associated With CLL

By: Sarah Campen, PharmD
Posted: Thursday, October 31, 2019

A study published in Immunity & Ageing revealed an increasing trend in the occurrence of certain chronic lymphocytic leukemia (CLL)-associated B-cell receptors as healthy individuals age. Alice F. Muggen, PhD, of Erasmus Medical Center in Rotterdam, The Netherlands, and colleagues found that the B-cell–receptor repertoire is relatively stable until age 70, whereupon “clear changes in IgHV gene usage were observed in naive mature B cells.”

The study evaluated the peripheral blood of 155 immunologically healthy individuals in four age categories. The total numbers and relative frequencies of B cells declined with age. Reductions in transitional B cells, memory cell types, and plasma blasts were seen in individuals 70 years and older along with changes in IgHV-gene usage in naive mature B cells. They also found a transitional pattern in IgHV-gene usage in those between age 50 and 70.

Notably, IgHV-gene usage in the clonal B-cell–receptor repertoire in CLL did not differ with the age of presentation in patients with CLL and largely resembled naive mature B cells of those between age 50 and 70 rather than 70 years and older. Additionally, CLL-associated stereotypic B-cell receptors were found to be part of the healthy control range of B-cell receptors, with an age-associated increase in frequency of several stereotypic B-cell receptors.

Disclosure: The study authors reported no conflicts of interest.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.